¿À½ÂÇå
½Å°æ°úÀå
³ú½Å°æ¼¾ÅÍÀå
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ¸»ÃÊÁúȯ/³úÁ¹Áß
Á÷
ˤ
: ±³¼ö(½Å°æ°úÀå,³ú½Å°æ¼¾ÅÍÀå)
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
31
±¹³»
ÆÄŲ½¼º´ Ä¡¸Å¿Í ·çÀ̼Òü Ä¡¸Å ȯÀÚ¿¡¼ ÀÎÁö±â´É°ú º¸È£ÀÚ ºÎ´ãÀÇ Â÷ÀÌÁ¡, 2020-04-04, ³ëÀÎÁ¤½ÅÀÇÇÐ
30
±¹³»
Tonic Upward Eyeball Deviation Mimicking Non-Convulsive Occipital Lobe Status Epilepticus That Was Induced by Hydrocephalus, 2018-06-25, Journal of epilepsy research
29
ÇØ¿Ü
The novel microRNA smR-164 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP, 2018-04-12, Lung cancer (Amsterdam, Netherlands)
28
ÇØ¿Ü
The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer, 2018-02-19, Cell Death Disease
27
ÇØ¿Ü
The impact of statin therapy after surgical or endovascular treatment of cerebral aneurysms., 2019-03-08, Journal of neurosurgery
26
ÇØ¿Ü
The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model, 2018-04-25, Cytotherapy
25
±¹³»
Reliability and Validity of the Korean Short-form Eight-item Parkinson¡¯s Disease Questionnaire (PDQ-8), 2020-05-04, º¸°ÇÁ¤º¸Åë°èÇÐȸÁö
24
ÇØ¿Ü
Pisa Syndrome in Parkinson"s Disease: Pathogenic Roles of Verticality Perception Deficits., 2018-01-11, Scientific reports
23
ÇØ¿Ü
Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington¡¯s Disease, 2020-08-17, Frontiers in neuroscience
22
ÇØ¿Ü
Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington¡¯s disease, 2020-08-11, Cell proliferation
1
2
3
4
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729